Osteopontin Contributes to Allergic Contact Dermatitis

Author: American Journal of Pathology
Published: 2009/12/29 - Updated: 2018/03/16
Peer-Reviewed: N/A
Contents: Summary - Main - Related Publications

Synopsis: Allergic contact dermatitis is a hyper-reaction of the immune system to either allergens or irritants on the skin.

Dr. Johannes M. Weiss and colleagues at the University of Ulm, Ulm, Germany have discovered that osteopontin (OPN) contributes to allergic contact dermatitis. They present these findings in the January 2010 issue of the American Journal of Pathology.

Main Digest

Dr. Johannes M. Weiss and colleagues at the University of Ulm, Ulm, Germany have discovered that osteopontin (OPN) contributes to allergic contact dermatitis. They present these findings in the January 2010 issue of the American Journal of Pathology.

Allergic contact dermatitis is a hyper-reaction of the immune system to either allergens or irritants on the skin, such as poison ivy, nickel, or latex.

Contact dermatitis results in large, burning, and itchy rashes, which can take anywhere from several days to weeks to heal.

Once allergic contact dermatitis occurs, only strict avoidance can prevent a recurrence, and there is no method to resist persistent sensitization.

Seier et al hypothesized that OPN, an immune mediator that has been shown to worsen the effects of autoimmune disease, played a role in eliciting and facilitating chronic allergic contact dermatitis.

They found that both skin cells and immune cells secreted OPN in allergic contact dermatitis lesions.

OPN was strongly induced in antigen-specific immune cells in a murine model of chronic contact hypersensitivity, and OPN-deficient mice had a less severe chronic contact hypersensitivity response.

As anti-OPN antibody treatment partially suppressed the symptoms of chronic contact hypersensitivity, OPN may serve as a new therapeutic target for allergic contact dermatitis.

Dr. Weiss's group suggests that "[their] data support a model in which OPN has an important function for [immune]-mediated skin inflammation, which may open the perspective to use anti-OPN antibody preparations for the treatment of therapy refractory [immune] cell-mediated skin disease."

Seier AM, Renkl AC, Schulz G, Uebele T, Sindrilaru A, Iben S, Liaw L, Kon S, Uede T Weiss JM: Antigen-Specific Induction of Osteopontin Contributes to the Chronification of Allergic Contact Dermatitis. Am J Pathol 2010, 176: 246-258

Attribution/Source(s):

This quality-reviewed publication pertaining to our Dermatology section was selected for circulation by the editors of Disabled World due to its likely interest to our disability community readers. Though the content may have been edited for style, clarity, or length, the article "Osteopontin Contributes to Allergic Contact Dermatitis" was originally written by American Journal of Pathology, and submitted for publishing on 2009/12/29 (Edit Update: 2018/03/16). Disabled World makes no warranties or representations in connection therewith.

📢 Discover Related Topics


👍 Share This Information To:
𝕏.com Facebook Reddit

Page Information, Citing and Disclaimer

Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. See our homepage for informative reviews, exclusive stories and how-tos. You can connect with us on social media such as X.com and our Facebook page.

Permalink: <a href="https://www.disabled-world.com/health/dermatology/osteopontin-dermatitis.php">Osteopontin Contributes to Allergic Contact Dermatitis</a>

Cite This Page (APA): American Journal of Pathology. (2009, December 29). Osteopontin Contributes to Allergic Contact Dermatitis. Disabled World. Retrieved February 22, 2024 from www.disabled-world.com/health/dermatology/osteopontin-dermatitis.php

Disabled World provides general information only. Materials presented are never meant to substitute for qualified professional medical care. Any 3rd party offering or advertising does not constitute an endorsement.